T1	Outcomes 760 772	relapse rate
T2	Outcomes 973 987	relapse rates,
T3	Outcomes 996 1018	relapse-free intervals
T4	Outcomes 1146 1174	number of peripheral T cells
T5	Outcomes 1183 1219	ability to become sensitized to DNCB
T6	Outcomes 1295 1310	blood monocytes
T7	Outcomes 1329 1387	monocytes capable of transforming into active macrophages,